Latest Strategic Transformation News

Page 1 of 13
RooLife Group Ltd has reported a 144% surge in half-year revenue to $3.75 million, driven by strong growth in proprietary product sales, notably its RLG Coffee range in China. The company also reduced its net loss by 23%, reflecting operational improvements and strategic divestments.
Victor Sage
Victor Sage
27 Feb 2026
WT Financial Group has reported robust half-year results for H1 FY2026, marked by a 20.8% increase in underlying net profit after tax and a fully franked interim dividend. The company’s strategic pivot to a business-to-business advice model and its Investco joint venture underpin its growth trajectory.
Claire Turing
Claire Turing
27 Feb 2026
Patrys Limited reported a near doubling of its half-year loss to $3.02 million, driven by restructuring and a strategic pivot including the acquisition of Reliis Pty Ltd. The company is advancing a dual-platform biotech strategy combining a clinical-stage CNS asset with its proprietary antibody platform.
Ada Torres
Ada Torres
26 Feb 2026
Emyria Limited has reported a significant 136% increase in revenue to $1.55 million for the half-year ended December 2025, driven by its expanding Empax clinic network and insurer-funded treatments across Australia. Despite this growth, the company posted a $2.37 million net loss, reflecting investments in scaling operations and infrastructure.
Ada Torres
Ada Torres
26 Feb 2026
Duxton Farms Limited reported a significant half-year loss driven by acquisition and integration costs following a major portfolio expansion. The company is navigating a strategic shift towards diversified agriculture with plans to stabilise earnings over the coming years.
Ada Torres
Ada Torres
26 Feb 2026
Nine Entertainment reports a 6% increase in Group EBITDA to $201 million and a 30% jump in net profit, driven by strong streaming and digital subscription growth amid strategic portfolio shifts.
Victor Sage
Victor Sage
24 Feb 2026
Southern Cross Media Group announces a significant reshuffle in its executive leadership following its recent merger, with CEO Jeff Howard stepping down and a global search underway for his successor.
Elise Vega
Elise Vega
23 Feb 2026
L1 Global Long Short Fund Limited reports a remarkable half-year turnaround with a 609% jump in net profit, driven by a new investment manager and a refreshed strategy. The company also declares a fully franked interim dividend as it completes a major equity raise and portfolio transition.
Claire Turing
Claire Turing
23 Feb 2026
Two capital raisings and one brutal reset set the tone, even as several companies posted clean growth or strong clinical updates. Radiopharmaceuticals kept delivering good news, but investors still punished supply-chain and cash needs fast.
Logan Eniac
Logan Eniac
21 Feb 2026
IDT Australia Limited has reported a significant narrowing of its half-year loss to $1.3 million, driven by stable revenues and operational efficiencies. The pharmaceutical manufacturer highlights growth in key segments despite some timing setbacks.
Victor Sage
Victor Sage
18 Feb 2026
SEEK Limited posted strong half-year revenue growth and record dividends, but a hefty impairment charge on its Chinese associate Zhaopin led to a significant net loss. The company’s strategic platform unification and Sidekicker reacquisition underpin operational momentum despite macroeconomic headwinds.
Sophie Babbage
Sophie Babbage
17 Feb 2026
Treasury Wine Estates reported a statutory loss driven by a significant US asset impairment but showed underlying growth in key markets. The company suspends its interim dividend and targets $100 million in annual cost savings through its TWE Ascent program.
Victor Sage
Victor Sage
16 Feb 2026